Skip to main content

Erythroleukoplakia clinical trials at UCSD
1 in progress, 0 open to eligible people

  • Pembrolizumab in Treating Participants With Leukoplakia

    Sorry, not yet accepting patients

    This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

    La Jolla, California and other locations

Last updated: